# Harvard Bioscience Inc: Form 8-K, filed Dec 17, 2025

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: 8-K
- Filed: 2025-12-17
- Accepted by EDGAR: Dec 17, 2025, 07:30 ET
- Period: 2025-12-17
- Accession: 0001171843-25-007972
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/f8k_121625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184325007972/f8k_121625.htm

Filed Dec 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-007972. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.